{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:11:22Z","timestamp":1791133882020,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,7,2]],"date-time":"2010-07-02T00:00:00Z","timestamp":1278028800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s11060-010-0281-y","type":"journal-article","created":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T08:08:05Z","timestamp":1277971685000},"page":"441-448","source":"Crossref","is-referenced-by-count":19,"title":["Lopinavir inhibits meningioma cell proliferation by Akt independent mechanism"],"prefix":"10.1007","volume":"101","author":[{"given":"Mahlon D.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Webster","family":"Pilcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,7,2]]},"reference":[{"key":"281_CR1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00165649","volume":"29","author":"M Bondy","year":"1996","unstructured":"Bondy M, Ligon BL (1996) Epidemiology and etiology of intracranial meningiomas: a review. J Neurooncol 29:197\u2013205","journal-title":"J Neurooncol"},{"key":"281_CR2","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3171\/jns.1992.77.4.0616","volume":"77","author":"H Maier","year":"1992","unstructured":"Maier H, Ofner D, Hittmair A et al (1992) Classic, atypical and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg 77:616\u2013623","journal-title":"J Neurosurg"},{"key":"281_CR3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0090-3019(86)90259-4","volume":"26","author":"J Jaaskelainen","year":"1986","unstructured":"Jaaskelainen J (1986) Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 637 patients. A multivariate analysis. Surg Neurol 26:461\u2013469","journal-title":"Surg Neurol"},{"key":"281_CR4","doi-asserted-by":"crossref","first-page":"936","DOI":"10.4065\/73.10.936","volume":"73","author":"SL Stafford","year":"1998","unstructured":"Stafford SL, Perry A, Suman VJ et al (1998) Primarily resected meningiomas: outcomes and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin Proc 73:936\u2013942","journal-title":"Mayo Clin Proc"},{"key":"281_CR5","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/00000478-199712000-00008","volume":"21","author":"A Perry","year":"1997","unstructured":"Perry A, Stafford SL, Scheithauer BW et al (1997) Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 21:1455\u20131465","journal-title":"Am J Surg Pathol"},{"key":"281_CR6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1227\/01.NEU.0000330399.55586.63","volume":"64","author":"MK Aghi","year":"2009","unstructured":"Aghi MK, Carter BS, Cosgrove GR et al (2009) Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64:56\u201360","journal-title":"Neurosurgery"},{"key":"281_CR7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3171\/jns.1994.80.2.0202","volume":"80","author":"JC Maroon","year":"1994","unstructured":"Maroon JC, Kennerdell JS, Vidovich DV, Alba A, Sternau L (1994) Recurrent spheno-orbital meningioma. J Neurosurg 80:202\u2013208","journal-title":"J Neurosurg"},{"key":"281_CR8","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/02688690802308687","volume":"22","author":"HJ Marcus","year":"2008","unstructured":"Marcus HJ, Price SJ, Wilby M et al (2008) Radiotherapy as an adjunct in the management of intracranial meningiomas: are we practicing evidence-based medicine? Br J Neurosurg 22:520\u2013528","journal-title":"Br J Neurosurg"},{"key":"281_CR9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.critrevonc.2008.01.010","volume":"67","author":"C Marosi","year":"2008","unstructured":"Marosi C, Hassler M, Roessler K et al (2008) Meningioma. Crit Rev Oncol Hematol 67:153\u2013171","journal-title":"Crit Rev Oncol Hematol"},{"key":"281_CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/02688690500080885","volume":"19","author":"I Malik","year":"2005","unstructured":"Malik I, Rowe JG, Walton L, Radatz MW, Kemeny AA (2005) The use of stereotactic radiosurgery in management of meningiomas. Br J Neurosurg 19:13\u201320","journal-title":"Br J Neurosurg"},{"key":"281_CR11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11060-007-9434-z","volume":"86","author":"MD Johnson","year":"2008","unstructured":"Johnson MD, Sade B, Milano MT, Lee JH, Toms SA (2008) New prospects for management and treatment of inoperable and recurrent skull base meningioma. J Neurooncol 86:109\u2013122","journal-title":"J Neurooncol"},{"key":"281_CR12","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3171\/FOC-07\/10\/E12","volume":"23","author":"AD Norden","year":"2007","unstructured":"Norden AD, Drappatz J, Wen PY (2007) Targeted drug therapy for meningiomas. Neurosurg Focus 23:E12","journal-title":"Neurosurg Focus"},{"key":"281_CR13","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3171\/jns.2002.97.3.0668","volume":"67","author":"MD Johnson","year":"2002","unstructured":"Johnson MD, Okediji E, Woodard A, Toms SA, Allen GA (2002) Evidence for phosphatidylinositol 3-kinase Akt-p70S6K pathway activation and transduction of mitogenic signals by platelet derived growth factor in human meningioma cells. J Neurosurg 67:668\u2013675","journal-title":"J Neurosurg"},{"key":"281_CR14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11060-008-9746-7","volume":"92","author":"MD Johnson","year":"2009","unstructured":"Johnson MD, O\u2019Connell M, Vito F, Bakos RS (2009) Increased STAT-3, synchronous activation of Raf-1-MEK-1-MAPK, phosphatidylinositol 3-kinase-Akt-mTOR pathways in atypical, anaplastic meningiomas. J Neurooncol 92:129\u2013135","journal-title":"J Neurooncol"},{"key":"281_CR15","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2664","volume":"9","author":"JA Engleman","year":"2009","unstructured":"Engleman JA (2009) Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 9:550\u2013562","journal-title":"Nat Rev Cancer"},{"key":"281_CR16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrc1479","volume":"4","author":"P Monini","year":"2004","unstructured":"Monini P, Sgadari C, Toschi E, Barillari G, Ensoli B (2004) Antitumour effects of antiretroviral therapy. Nat Rev Cancer 4:861\u2013875","journal-title":"Nat Rev Cancer"},{"key":"281_CR17","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1158\/1078-0432.CCR-05-1167","volume":"12","author":"A Srirangam","year":"2006","unstructured":"Srirangam A, Mitra R, Wang M et al (2006) Effects of HIV protease inhibitor amprenavir on Akt-regulated cell proliferation in breast cancer. Clin Cancer Res 12:1883\u20131896","journal-title":"Clin Cancer Res"},{"key":"281_CR18","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1158\/0008-5472.CAN-05-1220","volume":"65","author":"AK Gupta","year":"2005","unstructured":"Gupta AK, Cerniglia GJ, Mick R, McKenna WG, Muschel RJ (2005) HIV protease inhibitors block Akt signaling and radiosensitize tumor cells both in vitro and in vivo. Cancer Res 65:8256\u20138265","journal-title":"Cancer Res"},{"key":"281_CR19","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/sj.bjc.6603435","volume":"95","author":"Y Yang","year":"2006","unstructured":"Yang Y, Ikezoe T, Nishioka C et al (2006) NFV, and HIV-1 protease inhibitor, induces growth arrest, reduced Akt signaling, apoptosis and docetaxel sensitization in NSCLC cell lines. Br J Cancer 95:1653\u20131662","journal-title":"Br J Cancer"},{"key":"281_CR20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1476-4598-8-26","volume":"8","author":"S Kumar","year":"2009","unstructured":"Kumar S, Bryant CS, Chamala S, Qazi ASeward S et al (2009) Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells. Mol Cancer 8:26\u201330","journal-title":"Mol Cancer"},{"key":"281_CR21","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1593\/neo.06535","volume":"8","author":"N Pore","year":"2006","unstructured":"Pore N, Gupta AK, Cerniglia CJ, Mait A (2006) HIV-1 protease inhibitors decrease VEGF\/HIF-a expression and angiogenesis in glioblastoma cells. Neoplasia 8:889\u2013895","journal-title":"Neoplasia"},{"key":"281_CR22","doi-asserted-by":"crossref","first-page":"10920","DOI":"10.1158\/0008-5472.CAN-07-0796","volume":"67","author":"P Pyrko","year":"2007","unstructured":"Pyrko P, Kardosh A, Wang W, Xiong W, Schonthal AH, Chen TC (2007) HIV-1 protease inhibitors nelfinavir and atazanavir induce malignant glioma death by triggering endoplasmic reticulum stress. Cancer Res 67:10920\u201310928","journal-title":"Cancer Res"},{"key":"281_CR23","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1158\/0008-5472.CAN-06-3377","volume":"67","author":"W Jiang","year":"2007","unstructured":"Jiang W, Mikochik PJ, Ra JH et al (2007) HIV protease inhibitor nelfinavir inhibits growth of melanoma cells by induction of cell cycle arrest. Cancer Res 67:1221\u20131227","journal-title":"Cancer Res"},{"key":"281_CR24","first-page":"5230","volume":"62","author":"F Pajonk","year":"2002","unstructured":"Pajonk F, Himmelsbach J, Riess K, Sommer A, McBride WH (2002) The human immunodeficiency virus (HIV-1) protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells. Cancer Res 62:5230\u20135235","journal-title":"Cancer Res"},{"issue":"11","key":"281_CR25","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/NEN.0b013e3181bc6642","volume":"68","author":"MD Johnson","year":"2009","unstructured":"Johnson MD, O\u2019Connell MJ, Vito F, Pilcher W (2009) Bone morphogenetic protein 4 and its receptors are expressed in the leptomeninges and meningiomas and signal via the Smad pathway. J Neuropathol Exp Neurol 68(11):1177\u20131183","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"281_CR26","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.3171\/FOC-07\/10\/E9","volume":"23","author":"V Gupta","year":"2007","unstructured":"Gupta V, Samuleson CG, Su S, Chen TC (2007) Nelfinavir potentiation of imatinib cytotoxicity in meningioma cells via survivin inhibition. Neurosurg Focus 23(4):E9","journal-title":"Neurosurg Focus"},{"key":"281_CR27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/B:NEON.0000021823.05163.2c","volume":"67","author":"F Kayaselcuk","year":"2004","unstructured":"Kayaselcuk F, Forludemir S, Bal N, Erdogan B, Erdogan S, Erman T (2004) The expression of survivin and Ki-67 in meningiomas: correlation with grade and clinical outcome. J Neurooncol 67:209\u2013214","journal-title":"J Neurooncol"},{"key":"281_CR28","unstructured":"Lopinavir (2008) In Physicians Desk Reference, pp 458\u2013461"},{"key":"281_CR29","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1200\/JCO.2007.15.2355","volume":"26","author":"TB Brunner","year":"2008","unstructured":"Brunner TB, Geiger M, Grabenbauer GG, Lang-Welzenbach M, Mantoni TS, Cavallaro A, Sauer R, Hohenberger W, McKenna WG (2008) Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer. J Cin Oncol 26:2699\u20132706","journal-title":"J Cin Oncol"},{"key":"281_CR30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1158\/1535-7163.129.3.2","volume":"3","author":"N Laurent","year":"2004","unstructured":"Laurent N, de Bouard S, Guillamo JS et al (2004) Effects of the proteosome inhibitor ritonavir on glioma growth in vitro and in vivo. Mol Cancer Ther 3:129\u2013136","journal-title":"Mol Cancer Ther"},{"key":"281_CR31","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1158\/0008-5472.CAN-03-2677","volume":"64","author":"T Ikezoe","year":"2004","unstructured":"Ikezoe T, Hisatake Y, Takechuchi T et al (2004) HIV-1 protease inhibitor, ritonavir: a potent of CYP3A4, enhanced the anticancer effects of dodocetaxel in androgen-independent prostate cancer cells in vitro and in vivo. Cancer Res 64:7426\u20137431","journal-title":"Cancer Res"},{"key":"281_CR32","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2174\/157488409789375285","volume":"4","author":"NR Srinivas","year":"2009","unstructured":"Srinivas NR (2009) Is there a place for drug combination strategies using clinical pharmacology attributes-review of current trends in research. Curr Clin Pharmacol 4:220\u2013228","journal-title":"Curr Clin Pharmacol"},{"key":"281_CR33","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nrd1900","volume":"4","author":"KA O\u2019Connor","year":"2005","unstructured":"O\u2019Connor KA, Roth BL (2005) Finding new tricks for old drugs: an efficient route for public-sector drug discovery. Nat Rev Drug Discov 4:1005\u20131014","journal-title":"Nat Rev Drug Discov"},{"key":"281_CR34","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/COH.0b013e328313915d","volume":"3","author":"WB Bernstein","year":"2008","unstructured":"Bernstein WB, Dennis PA (2008) Repositioning HIV protease inhibitors as cancer therapeutics. Curr Opin HIV AIDS 3:666\u2013675","journal-title":"Curr Opin HIV AIDS"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-010-0281-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-010-0281-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-010-0281-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T21:00:18Z","timestamp":1685653218000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-010-0281-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,2]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["281"],"URL":"https:\/\/doi.org\/10.1007\/s11060-010-0281-y","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,2]]}}}